INO logo

INO
Inovio Pharmaceuticals Inc

92,360
Mkt Cap
$111.99M
Volume
419.00
52W High
$2.98
52W Low
$1.30
PE Ratio
-0.63
INO Fundamentals
Price
$1.63
Prev Close
$1.61
Open
$1.60
50D MA
$1.86
Beta
1.27
Avg. Volume
1.76M
EPS (Annual)
-$3.95
P/B
-11.31
Rev/Employee
$1,625.05
Loading...
Loading...
News
all
press releases
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Recommendation of "Hold" by Brokerages
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have been given an average recommendation of "Hold" by the eight research firms that are covering the stock, Marketbeat Ratings...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On...
PR Newswire·18d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...
PR Newswire·25d ago
News Placeholder
Looking Into Inovio Pharmaceuticals Inc's Recent Short Interest
read more...
Benzinga·1mo ago
News Placeholder
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of "Hold" by Analysts
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) have earned an average recommendation of "Hold" from the nine brokerages that are currently covering the stock, Marketbeat.com...
MarketBeat·1mo ago
News Placeholder
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of...
PR Newswire·1mo ago
News Placeholder
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO Reports Inducement Grant Under Inducement Plan INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Dec. 19, 2025 PLYMOUTH MEETING, Pa., Dec. 19, 2025...
PR Newswire·1mo ago
News Placeholder
INOVIO to Participate in December Investor Conferences
INOVIO to Participate in December Investor Conferences INOVIO to Participate in December Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 18, 2025 PLYMOUTH MEETING, Pa., Nov. 18, 2025...
PR Newswire·3mo ago
News Placeholder
Inovio (INO) Upgraded to Buy: Here's Why
Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·3mo ago
News Placeholder
Inovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) posted its earnings results on Monday. The biopharmaceutical company reported ($0.44) EPS for the quarter, topping the consensus estimate of...
MarketBeat·3mo ago
<
1
2
...
>

Latest INO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.